Gland Pharma’s board has approved the appointment of Shyamakant Giri as the new chief executive officer (CEO) of the company.

Merck, known as MSD outside of the United States and Canada, announced the presentation of positive results from the phase 2b/3 clinical trial (MK-1654-004) evaluating clesrovimab, the company’s ...

AbbVie announced that the US Food and Drug Administration (FDA) has approved Vyalev (foscarbidopa and foslevodopa) as the first and only subcutaneous 24-hour infusion of levodopa-based therapy for the ...

Dharmesh Kharwar joins Entod Pharmaceuticals as independent director: Our Bureau, Mumbai Saturday, October 19, 2024, 11:30 ...

Clarametyx reports progress on study of antibody therapy CMTX-101 for infections associated with CF, to begin phase 2a portion of the trial: Columbus, Ohio Saturday, October 19, 2 ...

Eterna Therapeutics collaborates with Factor Bioscience to speed up cell therapy development for oncology, autoimmune & rare diseases: Cambridge, Massachusetts Saturday, October 1 ...

Kane Biotech inks agreement with XSONX to distribute wound hygiene system in Canada, Australia, New Zealand & GCC countries: Winnipeg, Manitoba Saturday, October 19, 2024, 16:00 H ...

Univercells Technologies by Donaldson introduces scale-X nexo bioreactor for efficient cell culture process development across multiple modalities: Nivelles, Belgium Saturday, Oct ...

TuHURA Biosciences announces completion of merger transaction with Kintara Therapeutics: Tampa, Florida Saturday, October 19, 2024, 15:00 Hrs [IST] TuHURA Biosciences, a phase 3 r ...

EMA committee recommends marketing approval for Novartis’ Kisqali to help reduce risk of recurrence in people with HR+/HER2- early breast cancer: Basel Saturday, October 19, 202 ...

MJFF launches initiative to expedite development of LRRK2-targeted therapies and biomarkers for Parkinson’s disease: New York Saturday, October 19, 2024, 11:00 Hrs [IST] The Mic ...

Our Bureau, Mumbai Saturday, October 19, 2024, 12:30 Hrs [IST] ...